Clinical Trials · NCT07088718
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 44,671
- Start date
- Oct 2024
- Locations
- 1 site, United States
- Primary endpoint
- First occurence of MACE (all-cause mortailty, myocardial infarction, or death)